Study on the Prevalence of Hyperuricemia and Ethnobotanicals Associated with Gouty Arthritis in Rawalakot, Azad Kashmir

Journal Title: Open Access Journal of Pharmaceutical Research - Year 2022, Vol 6, Issue 1

Abstract

Hyperuricemia prevalence is an exclusive condition in the global populace as it seems to have increased day by day for a long time now. Recent studies recommend that hyperuricemia is an issue and is considered an independent risk. The prevalence of hyperuricemia in the patients of Azad Kashmir and the surveillance of medicinal plants used for this gouty arthritis is relatively low. However, to assess hyperuricemia prevalence in the Rawalakot region of Azad Kashmir, a review study was conducted. The data of the previous three years were retrieved from the Eastern Medicine Teaching Clinic at the University of Poonch, Combined Military Hospital (CMH) Rawalakot, as well as Ali Imran Hospital Rawalakot. Additionally, an ethnobotanical survey was performed to investigate the therapeutic plants utilized to cure gouty arthritis in the Rawalakot region of Azad Kashmir. The study observed a high incidence of hyperuricemia with joint pain in 17.4% of the 189 patients. The percentage of hyperuricemia in males was higher (10.5%) than in females (6.87%). These plants were identified and then evaluated by the local elder people and traditional healers (Hakims). Later on, it was then confirmed by the Botanical Department of University and then preserved. The ethnobotanical study revealed 13 medicinal plants belonging to 11 families used as medicines to treat gouty arthritis. Solanaceae was the most popular family with three species, Datura stramonium, Solanum nigrum, and Withania somnifera. It has been observed that people taking these medicinal plants have significant improvement in gouty arthritis. However, further study needs to be carried out to explore the bioactivity of the plants.

Authors and Affiliations

Aftab A, Akram M, khan FS, Gulzaib U, Hassan S, Hassan MM, Swargiary A, Islam MT, Chishti MA, Bhantana P, Singh A, Amer MM, Aslam MM, Parmar P, Mouna M, Inal B, Ibadi AK, Elkhateeb W* and Daba G

Keywords

Related Articles

Optimization and Formulation Design with In-Vitro Evaluation of Fast Disintegrating Tablets Containing Candesartan Solid Dispersions

The aim of this study was to assess the effects of processing parameters on the release of solid dispersion formulation from a fast dissolving tablet dosage form. Graphical and mathematical analysis such as the response...

Analgesic and Anti-inflammatory Properties of Argyreia Pilosa Wight & Arn

Background: Pain and inflammation are usually related to the pathophysiology of several medical conditions. The majority of antinociceptive and anti-inflammatory medications accessible within the merchandise found an out...

Benzimidazole:- A Versatile Moiety

Benzimidazole is a promising nitrogen-containing nucleus with extensive pharmacological activity, some of which are listed in this article, such as antiprotozoal, anthelmintic, antipsychotic, antiparasitic, antifungal,...

Chikungunya Emerging Health Crises in Pakistan: Are we Going in the Right Direction

The unstable health care system of Pakistan saw a major setback in the form of dengue outbreak in 2011. Despite massive governmental efforts, with each passing year dengue continues to cause significant morbidity and mo...

Lichen Secondary Metabolites as Anti-Fungal Agent: A Review

Lichens are found on every landform and have a history of use as food, medicine, dyes, livestock feed and other fields. The pharmaceutical potential of lichens is high and several companies are now attempting to commerc...

Download PDF file
  • EP ID EP748604
  • DOI 10.23880/oajpr-16000261
  • Views 70
  • Downloads 0

How To Cite

Aftab A, Akram M, khan FS, Gulzaib U, Hassan S, Hassan MM, Swargiary A, Islam MT, Chishti MA, Bhantana P, Singh A, Amer MM, Aslam MM, Parmar P, Mouna M, Inal B, Ibadi AK, Elkhateeb W* and Daba G (2022). Study on the Prevalence of Hyperuricemia and Ethnobotanicals Associated with Gouty Arthritis in Rawalakot, Azad Kashmir. Open Access Journal of Pharmaceutical Research, 6(1), -. https://www.europub.co.uk/articles/-A-748604